DeutschNewstral
Article
Ccontracostatimes.com on 2015-08-28 00:44
FDA lays out proposal for naming lower-cost biotech drugs
Related news
- CFDA lays out naming rules for lower-cost biotech drugscontracostatimes.com
FDA lays out proposal for naming generic biotech drugsobserver-reporter.com
FDA lays out proposal for naming lower-cost biotech drugsTimesDaily.com- FDA approves first lower-cost biotech drugobserver-reporter.com
FDA panel endorses first lower-cost biotech drugseattletimes.com- FDA approves lower-cost alternative to biotech drug Humiraseattletimes.com
Final WHO Biosimilar Naming Proposal Resembles FDA Approachjdsupra.com
Lower-cost biotech drug gets thumbs up from FDA panelreviewtimes.com- CFirst biosimilar drug approved by FDA, cheaper biotech medication on waycontracostatimes.com
- FDA Releases Naming Guidancejdsupra.com
- FDA Releases Biosimilar Naming Guidancejdsupra.com
FDA approves lower-cost alternative to drug Humirapressherald.com
FDA approves the first generic copy of a costly biotech drugThe Verge